Ruth Davies

Supplementary material from Barriers to sharing qualitative interview data and suggestions to overcome them: a scoping review

Evangeline Gowie, Anna Tsakalaki, Halena Lad, Ruth Davies et autres

Supplementary material.docx

Supplementary material from "Barriers to sharing qualitative interview data and suggestions to overcome them: a scoping review"

Evangeline Gowie, Anna Tsakalaki, Halena Lad, Ruth Davies et autres

Universities, journals and funding bodies increasingly encourage qualitative data sharing, yet practical guidance for making interview and focus group transcripts accessible remains difficult to locate. This scoping review maps actionable strategies to overcome barriers to sharing qualitative data. The review included all …

Supplementary material from "Barriers to sharing qualitative interview data and suggestions to overcome them: a scoping review"

Evangeline Gowie, Anna Tsakalaki, Halena Lad, Ruth Davies et autres

Universities, journals and funding bodies increasingly encourage qualitative data sharing, yet practical guidance for making interview and focus group transcripts accessible remains difficult to locate. This scoping review maps actionable strategies to overcome barriers to sharing qualitative data. The review included all …

Supplementary material from Barriers to sharing qualitative interview data and suggestions to overcome them: a scoping review

Evangeline Gowie, Anna Tsakalaki, Halena Lad, Ruth Davies et autres

Supplementary material.docx

Breaking barriers: Upfront expense payments to ease the economic burden for clinical trial patients.

Chiara Martinelli, Lyra Del Rosario, Jennifer Ball, Ruth Davies et autres

e23160 Background: Participation in clinical trials (CT) often imposes significant challenges on patients, beyond emotional and time commitments. The economic burden associated with being out-of-pocket (OOP) is a major barrier, particularly for individuals from lower socio-economic backgrounds, limiting their participation and retention …

gb, es (code pays fourni par la source)

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima H. Abbas, Jonathan Raihan Abbas et autres

BACKGROUND: Molnupiravir and nirmatrelvir-ritonavir are oral antivirals that have shown efficacy in preventing disease progression in outpatients with COVID-19. We aimed to evaluate these treatments for patients hospitalised with COVID-19 pneumonia, for whom data on these antivirals are scarce. METHODS: The RECOVERY …

Development of the Call Prioritisation Streaming System (CPSS) for NHS 111 Wales

Mike Brady, A M Lyall, Mark Conrad Fivaz, Craig M. Brown et autres

Introduction NHS 111 Wales is a free phone, nonemergency number that helps people get the right advice and treatment when needed. Clinicians, such as nurses and paramedics, work alongside health advisors to assess, advice and signpost patients. For various reasons, Welsh Ambulance …

gb (code pays fourni par la source)

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter AG Sandercock, Janet H Darbyshire, David L. DeMets, Robert Fowler et autres

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In …

gb, us, ca (code pays fourni par la source)

Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessment

Jeroen C. de Jonge, Wouter M. Sluis, Hendrik Reinink, Philip M. Bath et autres

Background: Infections and fever after stroke are associated with poor functional outcome or death. We assessed whether prophylactic treatment with anti-emetic, antibiotic, or antipyretic medication would improve functional outcome in older patients with acute stroke. Methods: We conducted an international, 2∗2∗2-factorial, randomised, …

de, nl, gb, no, hu, fr, ee, pl, gr, it (code pays fourni par la source)

Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

Giulio Francesco Romiti, Bernadette Corica, Marco Proietti, Davide Antonio Mei et autres

Background: Previous studies suggested potential ethnic differences in the management and outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription, discontinuation, and risk of adverse outcomes in Asian patients with AF, using data from a global prospective cohort …

gb, it, dk, fr, us, tw, nl (code pays fourni par la source)

Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry

Wern Yew Ding, Ameenathul M. Fawzy, Giulio Francesco Romiti, Marco Proietti et autres

The 2MACE score was specifically developed as a risk-stratification tool in atrial fibrillation (AF) to predict cardiovascular outcomes. We evaluated the predictive ability of the 2MACE score in the GLORIA-AF registry. All eligible patients from phase II/III of the prospective global GLORIA-AF …

gb, it, nl, dk (code pays fourni par la source)

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali H. Abbas, Fatima H. Abbas, Joshua Abbas et autres

BACKGROUND: Low-dose corticosteroids have been shown to reduce mortality for patients with COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation). We evaluated the use of a higher dose of corticosteroids in this patient group. …

gb (code pays fourni par la source)